Latest news on pediatric H1N1 vaccine recall

News broke earlier this week that some shipments of the H1N1 vaccine are being recalled amid concerns. You may be wondering what this news means for you and your family.

Vaccine manufacturer Sanofi Pasteur has notified the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) about a voluntary recall of their H1N1 pediatric vaccine due to reduced potency after delivery. According to the CDC, the vaccine potency is only slightly below the specified range. The vaccine in these specific lots is still expected to be effective in protecting children from getting the H1N1 flu but the government wanted to be cautious. There is no need to re-administer a dose to those who received vaccine from these lots.

According to the CDC, there are no safety concerns with any of the identified vaccine and infants and children who received the vaccine do not need to be revaccinated, said John Carpenter, M.D., director, division of infectious diseases at Scott & White Memorial Hospital.

Children nine years of age and under who are supposed to receive their second and final dose should still plan to receive it 21 days after their first dose from vaccine that is safe and has not been recalled.

Scott & White Healthcare did receive some of the Sanofi Pasteur H1N1 pediatric vaccine and will return it as specified by Sanofi Pasteur. This may affect currently scheduled appointments until we receive another shipment of H1N1 pediatric vaccine.

You will receive a call from your Scott & White physician’s office if there is a need to cancel appointments with pediatric patients until the new shipment is received.

This recall does not affect either the 0.5ml doses of H1N1 vaccine for children three years old and over and adults, or any of the H1N1 FluMist for children or adults, said Dr. Carpenter. This also does not affect any of the seasonal flu vaccine.

To read more about the recall, please visit the CDC recall Q&A page at:

http://www.cdc.gov/h1n1flu/vaccination/syringes_qa.htm

Scott & White continues to offer walk-in clinics and/or appointments for the H1N1 vaccine to patients of Scott & White.

1 thought on “Latest news on pediatric H1N1 vaccine recall”

  1. dentistryroseville

    The best treatment for influenza infections in humans is prevention by vaccination. Work by several laboratories has recently produced vaccines. The first vaccine released in early October 2009 was a nasal spray vaccine. It is approved for use in healthy individuals ages 2 through 49.

Leave a Reply

Flu

Latest news on pediatric H1N1 vaccine recall